- Commercial International reported a second-quarter profit of 16.71 billion pounds, beating estimates of 16.14 billion pounds.
- This represents a year-over-year profit increase of 7%.
- Net interest income rose to 25.94 billion pounds, marking a 14% increase compared to the previous year.
- Net fee and commission income increased by 21% year-over-year, reaching 2.22 billion pounds.
- Analyst recommendations for the company are strong, with 10 buy ratings and zero hold or sell ratings.
A look at Commercial International Bank Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Commercial International Bank Egypt SAE (CIB) is positioned for a positive long-term outlook based on its Smartkarma Smart Scores. With strong scores in Value, Growth, Resilience, and solid scores in Dividend and Momentum, CIB shows promising prospects in various key areas. The bank provides a range of financial services catering to enterprises, institutions, households, and high-net-worth individuals, including asset and liability products, wealth management, and investment banking. This diversified portfolio suggests a stable and growing business model that could perform well in the foreseeable future.
Commercial International Bank‘s high marks in Value, Growth, and Resilience indicate a solid foundation for potential long-term success. The bank’s offerings in life insurance, leasing & factoring, brokerage, and research further enhance its position in the market. While maintaining a noteworthy level of Momentum and Dividend performance, CIB’s strategic focus on providing comprehensive financial services has the potential to drive sustained growth and value creation over time.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
